Hopital Hotel Dieu Et Hme; Clinique Dermatologique

Nantes 44093

0 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, Basal Cell Carcinoma, Non-Hodgkin's Lymphoma

Studies at this site

• A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma — Completed
• A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN) — Completed
• A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis — Completed
• A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas — Completed